OpenVSafe by OpenVAERS
Search V-safe

EQA-17505-23016

2 vaccinations 2 coded responses 10 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
481 / MI
Registered
2021-01-15
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-15
    Registered in v-safe
  2. 2021-01-15
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-15
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  4. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  5. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-05
    Dose 2 — Pfizer-BioNTech
  10. 2021-02-05
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  11. 2021-02-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Emergency care, Heart rate increased, Hospitalisation, Laboratory test normal — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Systemic reaction (other): Developed rapid heart rate, 200 BPM, approximately 14 hours after injection requiring hospital stay · Healthcare visit (other): As previously mentioned, rapid heart rate of 200 BPM 14 hours after vaccination. Monitored in ER and admitted to observation as HR remained 120s at rest despite rehydration and labs within normal limits.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-07
    Report sent to call center — days 1–6 daily, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2021-07-15
  14. 2021-08-08
    Survey response — 6 months, dose 2
    MedDRA: Pregnancy — Feeling: Good
    Free text: Pregnancy
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  15. 2022-02-05
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-15Pfizer-BioNTech
22021-02-05Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 3 — days 1–6 daily, dose 2

2021-02-07

Systemic reaction (other): Developed rapid heart rate, 200 BPM, approximately 14 hours after injection requiring hospital stay
Healthcare visit (other): As previously mentioned, rapid heart rate of 200 BPM 14 hours after vaccination. Monitored in ER and admitted to observation as HR remained 120s at rest despite rehydration and labs within normal limits.

Release 9 — 6 months, dose 2

2021-08-08

Symptoms: Pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOEmergency care ✓ ✓ ✓
HCVOHeart rate increased ✓ ✓ ✓
HCVOHospitalisation ✓ ✓ ✓
HCVOLaboratory test normal ○ ✓ ○
SDPregnancy ✓ · ✓
SROHeart rate increased ✓ ✓ ✓
SROHospitalisation ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release